The following is a summary of “EDP-938 has a high barrier to resistance in healthy adults experimentally infected with ...

Recent health news highlights include Recordati's nonchalance towards potential U.S. tariffs, Canada's approval of Moderna's ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

Respiratory syncytial virus (RSV) infections are the leading ... RSV infection does not provoke lasting immunity, so human hosts experience lifelong cycles of infection and re-infection.

RSV can affect the lower respiratory tract ... and 6,000 to 10,000 deaths in older adults each year. The virus is highly transmissible, and a person can contract it via droplets released into ...

Respiratory syncytial virus, or RSV, typically presents as mild, with symptoms similar to the common cold for adults and ...

Ancient Viral DNA in the Human Genome Linked to Multiple Sclerosis ... of the effectiveness of the RSV -- short for respiratory syncytial virus -- vaccine. VISION ... Oct. 17, 2024 — It is ...

Source: Focus Medica. A viral infection of the respiratory tract caused by the virus Respiratory syncytial viru. This commonly affects children below the age of 2 years. Infection caused by the ...

A viral outbreak in Kolkata is causing dengue-like symptoms including high fever, joint pain, and rashes. Despite extensive testing, few patients are testing positive for dengue or malaria, leading ...

In 2023, 241 children under 5 years of age were hospitalised with a laboratory-confirmed RSV infection (i.e. cases), compared with 389 cases in 2022, representing decreases of 38% (389 vs 241 ...